New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction
Conditions
Colorectal Neoplasms - Neoplasm Metastasis - Liver Neoplasms - Chemotherapy; Maternal, Affecting Fetus
Conditions: official terms
Colorectal Neoplasms - Liver Neoplasms - Neoplasm Metastasis - Neoplasms
Study Type
Interventional
Study Phase
Phase 4
Study Design
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Intervention
Name: chemotherapy ± targeted therapy
Type: Drug
Overall Status
Recruiting
Summary
Evaluation of new adjuvant chemotherapy for unresectable liver metastasis of colorectal cancer without bleeding, obstruction, etc.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 75 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- age between 18 - 75 years old

- colorectal adenocarcinoma pathologically

- without any chemotherapy or radiotherapy

- unresectable liver metastasis and without other metastasis

- resectable colorectal cancer

- suitable for chemotherapy

- agreed by patients

Exclusion Criteria:

- age below 18 years old or greater than 75 years old

- haven't pathological diagnosis of colorectal adenocarcinoma

- with any chemotherapy or radiotherapy

- resectable liver metastasis or without other metastasis

- unresectable colorectal cancer

- unsuitable for chemotherapy

- not agreed by patients
Location
Zhongshan Hospital, Fudan University
Shanghai, Shanghai, China
Status: Recruiting
Contact: jianmin xu, doctor - 008613501984869 - xujmin@yahoo.com.cn
Start Date
January 2011
Completion Date
December 2015
Sponsors
Fudan University
Source
Fudan University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page